Keyword: Richard Gonzalez
Effective immediately, AbbVie is streamlining its executive team to four managers who will serve under CEO Richard Gonzalez.
Boehringer is hoping for big things from its Humira biosimilar in the U.S.—so much so that it’s giving up on copycat biologics in other countries.
AbbVie CFO Bill Chase will retire in 2019 after helming finance since the company's birth in 2013. He'll be replaced by controller Robert Michael.
AbbVie donated $100 million to Ronald McDonald House Charities this week, part of its ongoing 2018 tax-windfall handout of $350 million to charities.
AbbVie is bracing for European biosimilar competition to Humira, but the drug is still continuing its upward trajectory.
If you thought AbbVie CEO Richard Gonzalez spent a lot on personal air travel in 2016, check out 2017’s numbers.
The benefits of the upcoming tax overhaul will be so great that AbbVie is planning $2.5 billion in capital projects in the U.S.
AbbVie took a big step toward putting investors’ minds at ease about aging blockbuster Humira, with better-than-expected third-quarter results.
Facing backlash over reports that execs considered abandoning their pricing pledge, AbbVie said it's committed—at least through next year.